Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
JOP : Journal of the Pancreas|March 13, 2012
Resectable pancreatic cancer: is surgery the best first step?Suzanne Russo, John Chabot, Muhammad Wasif Saif
JOP : Journal of the Pancreas|July 9, 2011
Adjuvant treatment for ampullary cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011Richard Kim, John Chabot, Muhammad Wasif Saif
Current Treatment Options in Oncology|October 9, 2008
Peritoneal mesotheliomaMary E Hesdorffer, John Chabot, Carolyn DeRosa, et al.
JOP : Journal of the Pancreas|July 9, 2011
Adjuvant Therapy of Pancreatic Cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011Charu Sharma, David Horowitz, John Chabot, et al.
JOP : Journal of the Pancreas|July 6, 2010
Updates of adjuvant therapy in pancreatic cancer: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010Jia Li, Man Yee Merl, John Chabot, et al.
World Journal of Surgery|September 5, 2007
1112 consecutive bilateral neck explorations for primary hyperparathyroidismJohn Allendorf, Mary DiGorgi, Kathryn Spanknebel, et al.
The Journal of Clinical Endocrinology and Metabolism|July 5, 2003
The impact of sestamibi scanning on the outcome of parathyroid surgeryJohn Allendorf, Lucy Kim, John Chabot, et al.
Seminars in Oncology|October 24, 2018
Epidemiologic trends in neuroendocrine tumors: An examination of incidence rates and survival of specific patient subgroups over the past 20 yearsPaul E Sackstein, Daniel S O'Neil, Alfred I Neugut, et al.
Cancer Chemotherapy and Pharmacology|April 19, 2007
The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysisRobert L Fine, David R Fogelman, Stephen M Schreibman, et al.
Cancer|December 11, 2014
Neoadjuvant gemcitabine, docetaxel, and capecitabine followed by gemcitabine and capecitabine/radiation therapy and surgery in locally advanced, unresectable pancreatic adenocarcinomaWilliam H Sherman, Kyung Chu, John Chabot, et al.
Pageof 2